Trial site
Centre Hospitalier Régional et Universitaire de Brest
- 258running trials
- 73closed trials
The trials here
What the 335 trials at this site are about, from their registry records.
- Conditions
- Lung cancer39 trials
- Prostate cancer26 trials
- Childhood cancers18 trials
- Gastric and oesophageal cancer18 trials
- High blood pressure16 trials
- Asthma11 trials
- Colorectal cancer11 trials
- Pulmonary arterial hypertension11 trials
- Sjögren's disease11 trials
- Head and neck cancer10 trials
- Liver and biliary tract cancer10 trials
- Metastatic breast cancer10 trials
- and 69 more
- Phase
- Phase 3208 trials
- Phase 280 trials
- Phase 415 trials
- Phase 1/213 trials
- Phase 2/313 trials
- Phase 15 trials
- Status
- Recruiting140 trials
- Active, not recruiting87 trials
- Completed72 trials
- Not yet recruiting31 trials
- Suspended4 trials
- Withdrawn1 trial
- Lead sponsor
- AstraZeneca18 trials
- Novartis Pharmaceuticals17 trials
- Assistance Publique - Hôpitaux de Paris13 trials
- Merck Sharp & Dohme LLC13 trials
- GlaxoSmithKline8 trials
- and 144 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Analysis of histological risk factors and biomarkers in paediatric retinoblastoma
Not yet recruiting
Not yet recruiting
Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
CS1 Added to Standard of Care Therapy for Pulmonary Arterial Hypertension
Not yet recruiting
Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease
Recruiting
Recruiting
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Not yet recruiting
Not yet recruiting
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Recruiting
Recruiting
Recruiting
Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
Recruiting
COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Recruiting
Recruiting
Recruiting
Recruiting
Showing 50 of 258.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer17 recruiting
- Childhood cancers13 recruiting
- Prostate cancer9 recruiting
- Colorectal cancer8 recruiting
- Gastric and oesophageal cancer8 recruiting
- High blood pressure8 recruiting
- Pancreatic cancer7 recruiting
- Asthma6 recruiting
- Acute lymphoblastic leukaemia5 recruiting
- Bladder cancer5 recruiting
- Liver and biliary tract cancer5 recruiting
- Multiple myeloma5 recruiting
- Myeloproliferative neoplasms5 recruiting
- Pulmonary arterial hypertension5 recruiting
- ANCA-associated vasculitis4 recruiting
- Endometrial cancer4 recruiting
- Head and neck cancer4 recruiting
- Metastatic breast cancer4 recruiting
- Ovarian cancer4 recruiting
- Sjögren's disease4 recruiting
- COPD3 recruiting
- Multiple sclerosis3 recruiting
- Rheumatoid arthritis3 recruiting
- Acute myeloid leukaemia2 recruiting
- Atrial fibrillation2 recruiting
- Bronchiectasis2 recruiting
- Cystic fibrosis2 recruiting
- Deep vein thrombosis and pulmonary embolism2 recruiting
- Heart failure2 recruiting
- Hidradenitis suppurativa2 recruiting
- Idiopathic pulmonary fibrosis2 recruiting
- Sarcoma2 recruiting
- Stroke2 recruiting
- Systemic sclerosis (scleroderma)2 recruiting
- Thyroid cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Vitiligo2 recruiting
- Ankylosing spondylitis1 recruiting
- Aortic stenosis1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Brain metastases1 recruiting
- Cervical cancer1 recruiting
- Chronic kidney disease1 recruiting
- Chronic spontaneous urticaria1 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Coronary artery disease1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Epidermolysis bullosa1 recruiting
- Follicular lymphoma1 recruiting
- Gout1 recruiting
- Kidney cancer1 recruiting
- Lichen planus1 recruiting
- Liver cirrhosis1 recruiting
- Lupus (SLE)1 recruiting
- Meningioma1 recruiting
- Neuroendocrine tumours1 recruiting
- Obesity1 recruiting
- Polycystic kidney disease1 recruiting
- Polymyalgia rheumatica1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Spinal muscular atrophy1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC
Completed
Recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Active, not recruiting
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Completed
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Premedication to Reduce Amivantamab Associated Infusion Related Reactions
Completed
Completed
Completed
Completed
Recruiting
Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Active, not recruiting
Completed
Completed
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
Active, not recruiting
Completed
Completed
Completed
Completed
A Long-term Follow-up Study of Sotatercept for PAH Treatment
Completed
Recruiting
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Showing 50 of 73.
Site data: ClinicalTrials.govUpdated 18 Nov 2026